The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global bromelain market grew at a CAGR of around 5% during 2015-2020. Looking forward, IMARC Group expects the market to exhibit moderate growth during the next five years. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use industries. These insights are included in the report as a major market contributor.
Bromelain is a protease or protein-digesting enzyme derived from the fruit and stem of the pineapple plant. It is an inhibitor of blood platelet aggregation, which minimizes the risk of arterial thrombosis and embolism and consequently finds extensive utilization in the treatment of cardiovascular diseases (CVDs). It is also an effective fibrinolytic agent as it stimulates the conversion of plasminogen to plasmin and increases fibrinolysis. Moreover, it is gaining traction as an alternative treatment to nonsteroidal anti-inflammatory drugs (NSAIDs) in homeopathy. Besides this, topical bromelain administration as a cream is considered beneficial for burns debridement.
The market growth can be primarily accredited to the extensive applications of bromelain in the healthcare and pharmaceutical industries worldwide. It is utilized as a dietary supplement for reducing pain, swelling and bruising after surgery. It is also helpful in relieving certain symptoms of osteoarthritis, diarrhea and diabetes, and enhancing absorption of drugs like antibiotics. Moreover, the growing prevalence of CVDs is fueling the market growth. Apart from this, bromelain is utilized by sports professionals to treat acute inflammation in case of injuries. It further finds application in treating chronic inflammatory, malignant and autoimmune diseases. Additionally, as it can be absorbed in the intestines without degrading and losing biological activity, it is gaining traction in the development of oral enzyme therapies for oncology patients. This, along with the expanding usage of bromelain as a meat tenderizer in the food and beverage (F&B) industry, is anticipated to positively influence the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global bromelain market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, source and application.
Breakup by Source:
Breakup by Application:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Advanced Enzyme Technologies Limited, Bio-gen Extracts Private Limited., Changsha Natureway Co. Ltd., Creative Enzymes, Enzybel International (Floridienne S.A.), Enzyme Development Corporation, Enzyme Technologies (PTY) Ltd., Guangxi Nanning Javely Biological Products Co. Ltd., Hong Mao Biochemicals Co. Ltd., Mitushi Biopharma and Xena Bio Herbals Pvt. Ltd.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at